[HTML][HTML] Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and …
MG Salem, SAA El-Ata, EH Elsayed, SN Mali… - RSC …, 2023 - pubs.rsc.org
Breast cancer is a global health concern, with increasing disease burden and disparities in
access to healthcare. Late diagnosis and limited treatment options in underserved areas …
access to healthcare. Late diagnosis and limited treatment options in underserved areas …
Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity
MG Salem, SA Abu El-ata, EH Elsayed… - RSC …, 2023 - ui.adsabs.harvard.edu
We reported a novel 2-coumarin-substituted-quinoxaline analogue (3b) with potential
antiproliferative activity against MCF-7 breast cancer cells by inducing cell cycle arrest and …
antiproliferative activity against MCF-7 breast cancer cells by inducing cell cycle arrest and …
[HTML][HTML] Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and …
MG Salem, SAA El-ata, EH Elsayed, SN Mali… - RSC …, 2023 - ncbi.nlm.nih.gov
Breast cancer is a global health concern, with increasing disease burden and disparities in
access to healthcare. Late diagnosis and limited treatment options in underserved areas …
access to healthcare. Late diagnosis and limited treatment options in underserved areas …
Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity
MG Salem, SAA El-Ata, EH Elsayed… - RSC …, 2023 - pubmed.ncbi.nlm.nih.gov
Breast cancer is a global health concern, with increasing disease burden and disparities in
access to healthcare. Late diagnosis and limited treatment options in underserved areas …
access to healthcare. Late diagnosis and limited treatment options in underserved areas …
Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity …
M Salem, E Elsayed, S Mali, H Alshwyeh… - RSC …, 2023 - europepmc.org
Breast cancer is a global health concern, with increasing disease burden and disparities in
access to healthcare. Late diagnosis and limited treatment options in underserved areas …
access to healthcare. Late diagnosis and limited treatment options in underserved areas …
Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity …
MG Salem, AEA SA, EH Elsayed, SN Mali… - RSC …, 2023 - europepmc.org
Breast cancer is a global health concern, with increasing disease burden and disparities in
access to healthcare. Late diagnosis and limited treatment options in underserved areas …
access to healthcare. Late diagnosis and limited treatment options in underserved areas …